Sharekhan

Dishman Carbogen Amcis Ltd

Sun 1/02/2026,11:29:54 NSE: DCAL

₹ 223.28 4.81 (2.20%)
BUY NOW Buy Dishman Carbogen Amcis Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Dishman Carbogen Amcis Ltd

Sun 1/02/2026,11:43:0

Dishman Carbogen Amcis Ltd

Sun 1/02/2026,11:29:54 | NSE : DCAL

₹ 223.284.81 (2.20%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 217.40

Previous Close

₹ 218.47

Volume

29203

Mkt Cap ( Rs. Cr)

₹3500.65

High

₹ 224.40

Low

₹ 217.00

52 Week High

₹ 321.95

52 Week Low

₹ 178.00

Book Value Per Share

₹ 405.97

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Dishman Carbogen Amcis Ltd

Your Vote -

Buy

73.91%

Hold

10.87%

Sell

15.22%

73.91%

46 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

50%

Sell Order Quantity

50%

Bid Price

Qty

221.00

66

221.00

10

221.00

3

221.00

3

221.00

11

Bid Total

47807

Bid Price

Qty

221.41

9

221.00

20

221.00

13

222.00

1

222.00

7

Bid Total

47170

Option Chain

Analyzes market sentiment, predicts Dishman Carbogen Amcis Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dishman Carbogen Amc - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Jan 2026, 6:39PM Dishman Carbogen Amcis Limited has informed the Exchange about Schedule of meet

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Jan 2026, 6:34PM The Company has arranged Conference Call with Investors on Wednesday, 4th February, 2026 at 15:00 hrs. (IST) to discuss the financial result and perfo

  • Dishman Carbogen Amc - Board Meeting Intimation for Considering, Take On Record And Approve The Un-Audited Financial Results

    29 Jan 2026, 1:09PM Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consid

  • Dishman Carbogen Amc has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    21 Jan 2026, 8:00PM As of December 2025, 59.32% is owned by Indian Promoters and 40.68% by Public. <p align=justify> Top Promoter holding highest number of shares of Dish

  • Dishman Carbogen Amc - Allotment of Securities

    20 Jan 2026, 12:46PM Dishman Carbogen Amcis Limited has informed the Exchange regarding allotment of 5000 securities pursuant to Non Convertible Securities at its meeting

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Allotment

    20 Jan 2026, 12:39PM Pls. find attached herewith intimation of allotment of 5000 NCDs.

  • Dishman Carbogen Amc - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    12 Jan 2026, 3:45PM Dishman Carbogen Amcis Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Dishman Carbogen Amc - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Jan 2026, 3:42PM Please find attached herewith Certificate under Regulation 74(5) of SEBi (DP) Regulations, 2018.

  • Dishman Carbogen Amc - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Jan 2026, 6:57PM Dishman Carbogen Amcis Limited has informed the Exchange about Schedule of meet

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Jan 2026, 6:55PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform that the schedule of Ana

  • Dishman Carbogen Amc - Outcome of Board Meeting

    27 Dec 2025, 1:02PM Dishman Carbogen Amcis Limited has informed the Exchange regarding BOARD APPROVES ISSUE OF SENIOR, SECURED, RATED, LISTED, TRANSFERABLE, TAXABLE, REDE

  • Dishman Carbogen Amc - Outcome of Board Meeting

    27 Dec 2025, 12:59PM Dishman Carbogen Amcis Limited has informed the Exchange regarding BOARD APPROVES ISSUE OF SENIOR, SECURED, RATED, LISTED, TRANSFERABLE, TAXABLE, REDE

  • Dishman Carbogen Amc - Board Meeting Outcome for BOARD MEETING OUTCOME FOR BOARD APPROVES ISSUE OF SENIOR, SECURED, RATED, LI

    27 Dec 2025, 12:56PM We would like to inform you that the Board of Directors of the Company has at its meeting held today, i.e., Saturday, December 27, 2025 which was comm

  • Dishman Carbogen Amc - Trading Window

    23 Dec 2025, 8:33PM Dishman Carbogen Amcis Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula

  • Dishman Carbogen Amc - Board Meeting Intimation for Considering And Approving The Proposal Of Fund Raising By Way Of Issuance

    23 Dec 2025, 8:01PM Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/12/2025 ,inter alia, to consid

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 Dec 2025, 3:13PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform that the schedule of Ana

  • Dishman Carbogen Amc - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Dec 2025, 3:13PM Dishman Carbogen Amcis Limited has informed the Exchange about Schedule of meet

  • Dishman Carbogen Amc - Press Release

    12 Nov 2025, 12:47PM Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated November 12, 2025, titled ""COMPANY S WHOLLY-OWNED SUBSIDIARY

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    12 Nov 2025, 12:46PM Pls. find enclosed herewith Press Release under Regulations 30 and 51 of the SEBI (LODR) Regulations, 2015.

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    11 Nov 2025, 6:16PM PFA transcript of Con Call held on 05.11.2025.

  • Dishman Carbogen Amc - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Nov 2025, 6:14PM Dishman Carbogen Amcis Limited has informed the Exchange about Transcript

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    5 Nov 2025, 7:18PM Pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, the audio recording of Conference

  • Dishman Carbogen Amc - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Nov 2025, 7:18PM Dishman Carbogen Amcis Limited has informed the Exchange about Link of Recording

  • Dishman Carbogen Amc - Press Release

    5 Nov 2025, 7:11PM Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated November 05, 2025, titled ""PRESS RELEASE ON UN-AUDITED FINAN

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    5 Nov 2025, 7:11PM Pls. find enclosed herewith Press Release on UFR 30.09.2025.

  • Dishman Carbogen Amc - Investor Presentation

    5 Nov 2025, 2:43PM Dishman Carbogen Amcis Limited has informed the Exchange about Investor Presentation

  • Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Investor Presentation

    5 Nov 2025, 2:43PM Pls. find attached herewith Investor Presentation on UFR 30.09.2025.

  • Dishman Carbogen Amc posts Q2 net loss of Rs 13.60 cr

    4 Nov 2025, 10:54PM The company reported standalone net loss during the quarter stood at Rs 13.60 crore compared to net profit of Rs 14.25 crore in the previous year quar

  • Dishman Carbogen Amc - Outcome of Board Meeting

    4 Nov 2025, 10:50PM Dishman Carbogen Amcis Limited has informed the Exchange regarding Board meeting held on November 04, 2025.

  • Dishman Carbogen Amc - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th Septemb

    4 Nov 2025, 10:13PM Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2025.

  • Dishman Carbogen Amc - Outcome of Board Meeting

    4 Nov 2025, 10:12PM Dishman Carbogen Amcis Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

  • Dishman Carbogen Amc - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2025.

    4 Nov 2025, 10:06PM Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2025.

  • Dishman Carbogen Amics

    17 Jan 2020 , 1:15PM Board has approved share buyback up to a maximum of 48 lakh shares or 2.97% equity at price of Rs 150 aggregating to Rs 72 crore. The buyback price is at a premium of 69 % to closing prices of Rs 88.7 as 16 Jan 2020. Post the share buyback, the promoters stake expected to increase to 63.28% from 61.4%, while public shareholders stake to fall to 36.72% from 38.6%.

  • Dishman Carbogen drops after I-T search, survey

    20 Dec 2019 , 11:00AM Dishman Carbogen slips by 12% to Rs. 97, a major search and survey was carried out by the state income tax

  • Dishman Carbogen's founder Janmejay Vyas steps down as MD

    18 Feb 2019 , 4:51PM Global MD Arpit Vyas takes over Janmejay Vyas's duties

  • Dishman gets EIR from USFDA for Bavla unit

    29 Jan 2019 , 12:01PM Bavla unit receives Establishment Inspection Report from USFDA

  • Dishman Carbogen hits 5% upper circuit

    28 Sep 2017 , 2:57PM Dishman Carbogen hits 5% upper circuit, after its Switzerland unit receives zero observations from the US health regulator

  • Dishman Carbogen to be listed today

    21 Sep 2017 , 11:25AM Dishman Carbogen Amcis Limited (DCAL – 540701), erstwhile Dishman Pharmaceutical Limited, will be listed today (21st September 2017) in T2T segment for 10 days.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Dishman Carbogen Amcis Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 4709.04 4576.56 4704.16 4758.74 5200.89
Liabilities 4709.04 4576.56 4704.16 4758.74 5200.89
Equity 31.36 31.36 31.36 31.36 31.36
Gross Profit 71.79 6.8 7.76 34.19 -52.65
Net Profit -9.87 -76.41 -58.87 -31.55 -232.81
Cash From Operating Activities 55.81 24.17 -52.9 227.35 -1.51
NPM(%) -2.46 -23.34 -14.62 -10.41 -116.21
Revenue 399.84 327.35 402.55 302.79 200.32
Expenses 328.05 320.55 394.79 268.6 252.97
ROE(%) -0.15 -1.2 -0.92 -0.49 -3.65

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
12 Sep 2019 0.2 10 0 219.9

Peers

Other companies within the same industry or sector that are comparable to Dishman Carbogen Amcis Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Inox Green Energy Services Ltd 174.00 2.38 117.57 7558.71 4.93 0.00
Prozone Realty Ltd 50.99 1.86 0.00 3142.86 -124.26 0.00
Sahyadri Industries Ltd 249.90 0.18 14.78 225.52 177.78 0.40
Jindal Photo Ltd 1415.90 1.37 9.45 211.27 2202.55 0.00

Company Info

The Company was originally incorporated as Carbogen Amcis (India) Limited on July 17, 2007 under the Companies Act, 1956 with the Registrar of Companies, Gujarat. Pursuant to the Scheme of Arrangement and Amalgamation sanctioned by the Hon'ble High Court of Gujarat at Ahmedabad vide its order dated December 16, 2016, the name was changed to Dishman Carbogen Amcis Limited vide a fresh Certificate of Incorporation dated 27th March, 2017 issued by the aforesaid Registrar of Companies. 2017 -Company name has changed to Dishman Carbogen Amcis Ltd. from Carbogen Amcis (India) Ltd. 2019 -Dishman Carbogen Amcis Limited has informed the Exchange about Acquisition of Dishman Biotech Limited. 2021- Dishman Carbogen Amcis Limited's subsidiary has releases new product alongwith NH TherAguix 2024-Dishman Carbogen Amcis Ltd received the Choose France-Best Indian Investment in France award by the Indo French Chamber of Commerce & Industry in partnership with Business France India, at the sixth flagship event of the Indo-French Business Awards (IFBA) and Grand Prix VIE, in New Delhi-Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), receives the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) certification.

The Company was originally incorporated as Carbogen Amcis (India) Limited on July 17, 2007 under the Companies Act, 1956 with the Registrar of Companies, Gujarat. Pursuant to the Scheme of Arrangement and Amalgamation sanctioned by the Hon'ble High Court of Gujarat at Ahmedabad vide its order dated December 16, 2016, the name was changed to Dishman Carbogen Amcis Limited vide a fresh Certificate of Incorporation dated 27th March, 2017 issued by the aforesaid Registrar of Companies. 2017 -Company name has changed to Dishman Carbogen Amcis Ltd. from Carbogen Amcis (India) Ltd. 2019 -Dishman Carbogen Amcis Limited has informed the Exchange about Acquisition of Dishman Biotech Limited. 2021- Dishman Carbogen Amcis Limited's subsidiary has releases new product alongwith NH TherAguix 2024-Dishman Carbogen Amcis Ltd received the Choose France-Best Indian Investment in France award by the Indo French Chamber of Commerce & Industry in partnership with Business France India, at the sixth flagship event of the Indo-French Business Awards (IFBA) and Grand Prix VIE, in New Delhi-Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), receives the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) certification.

Read More

Parent Organisation

Dishman Carbogen Amcis Ltd.

Founded

17/07/2007

Managing Director

Mr.Arpit J Vyas

NSE Symbol

DCALEQ

FAQ

The current price of Dishman Carbogen Amcis Ltd is ₹ 223.28.

The 52-week high for Dishman Carbogen Amcis Ltd is ₹ 224.40 and the 52-week low is ₹ 217.00.

The market capitalization of Dishman Carbogen Amcis Ltd is currently ₹ 3500.65. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dishman Carbogen Amcis Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dishman Carbogen Amcis Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dishman Carbogen Amcis Ltd shares.

The CEO of Dishman Carbogen Amcis Ltd is Mr.Arpit J Vyas, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT